苯甲腈,2-氟-,N-氧化 | 139060-01-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 苯甲腈,2-氟-,N-氧化
• 英文名称: 2-Fluoro-benzonitrile N-oxide
• 英文别名: 2-Fluorobenzonitrile oxide
• CAS: 139060-01-8
• 化学式: C₇H₄FNO
• 分子量: 137.113
• InChiKey: CNNCTCVXWRDLOR-UHFFFAOYSA-N

物化性质

• 密度：
  1.12±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.0
• 重原子数：
  10.0
• 可旋转键数：
  0.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  27.42
• 氢给体数：
  0.0
• 氢受体数：
  1.0

反应信息

• 作为反应物：
  描述：

  苯甲腈,2-氟-,N-氧化 在 sodium tetrahydroborate 、 magnesium(II) perchlorate 、 三乙胺 作用下， 以 乙醚 为溶剂， 反应 25.0h， 生成 3-(2-fluorophenyl)-5-(3,5-dichlorophenylcarbamoyl)-5-hydroxymethyl-5-methylisoxazoline
  参考文献：
  名称：

  Synthesis and Fungicidal Activity of Isoxazolines Fused to 3,5-Dichloromaleimide

  摘要：

  通过将取代苯甲腈氧化物I加到N-(3,5-二氯苯基)马来酰亚胺（I，R = H）或其甲基衍生物II（R = CH3）上，制备了3-苯基-5-(3,5-二氯苯基)-3a,4,6,6a-四氢吡咯并[3,4-d]异噁唑酮（III，R = H）和3-苯基-5-(3,5-二氯苯基)-6a-甲基-3a,4,6,6a-四氢吡咯并[3,4-d]异噁唑酮（IV，R = CH3）。与化合物II（R = CH3）的环加成反应是区域选择性的。用NaBH4还原IVg，区域和立体选择性地生成羟基内酰胺VIIg，VIIIg和IXg。几种产品的抗真菌活性不如商业制剂。

  DOI：

  10.1135/cccc19921521
• 作为产物：
  描述：

  2-fluoro-N-hydroxybenzenecarboxymidoyl chloride 在 potassium carbonate 作用下， 以 水 为溶剂， 生成 苯甲腈,2-氟-,N-氧化
  参考文献：
  名称：

  二苯并氮杂连接的异恶唑：新型有效的α-葡萄糖苷酶抑制剂

  摘要：

  α-葡萄糖苷酶抑制是控制糖尿病高血糖的有效方法。在目前的研究中，根据他们作为抗糖尿病药物的文献，设计了作为异恶唑和二苯并氮杂支架混合体的新分子。为此，使用氧化腈-炔环加成 (NOAC) 反应制备了一系列二苯并氮杂连接的异恶唑 ( 33-54 )，并评估了它们的α-葡萄糖苷酶抑制活性，以探索治疗糖尿病的新方法。大多数化合物显示出对强效的抑制效力α葡糖苷酶（EC 3.2.1.20）的酶（IC 50 = 35.62±1.48至333.30±1.67 μ M）使用阿卡波糖作为参考药物（IC 50= 875.75 ± 2.08 µ M)。还确定了活性异恶唑的构效关系、动力学和分子对接研究，以研究酶-抑制剂相互作用。化合物33，40，41，46，48-50，和54显示结合与关键的氨基酸残基相互作用α葡糖苷酶的酶，如Lys156，Ser157，Asp242和Gln353。

  DOI：

  10.1016/j.bmcl.2021.127979

文献信息

• Discovery and characterization of potent spiro-isoxazole-based cereblon ligands with a novel binding mode
  作者：Robert Shevalev、Luca Bischof、Alexander Sapegin、Alexander Bunev、Grigor'eva Olga、Grigory Kantin、Stanislav Kalinin、Marcus D. Hartmann

  DOI：10.1016/j.ejmech.2024.116328

  日期：2024.4

  The vast majority of current cereblon (CRBN) ligands is based on the thalidomide scaffold, relying on glutarimide as the core binding moiety. With this architecture, most of these ligands inherit the overall binding mode, interactions with neo-substrates, and thereby potentially also the cytotoxic and teratogenic properties of the parent thalidomide. In this work, by incorporating a spiro-linker to

  目前绝大多数的 cereblon (CRBN) 配体都是基于沙利度胺支架，依靠戊二酰亚胺作为核心结合部分。通过这种结构，大多数配体继承了整体结合模式、与新底物的相互作用，从而也继承了母体沙利度胺的潜在细胞毒性和致畸特性。在这项工作中，通过将螺接头结合到戊二酰亚胺部分，我们产生了一种新的化学型，该化学型对基于戊二酰亚胺的 CRBN 配体表现出前所未有的结合模式。总共合成了 16 种包含异恶唑部分的螺环戊二酰亚胺衍生物，并根据不同的标准进行了测试。特别是，所有配体均表现出良好的亲脂性，其中一些配体的结合亲和力能够超过作为参考的沙利度胺。此外，所有化合物在骨髓瘤细胞系和人外周血单核细胞中均表现出良好的细胞毒性。我们在共晶结构中确定的新型结合模式为这些改进的特性提供了解释：螺异恶唑的掺入改变了经典三色氨酸口袋内戊二酰亚胺部分的构象以及突出部分的方向。在这个新的方向上，它形成额外的疏水相互作用，并且
• Design, Synthesis, and Evaluation of Hydroxamic Acid Derivatives as Promising Agents for the Management of Chagas Disease
  作者：Giseli Capaci Rodrigues、Daniel Ferreira Feijó、Marcelo Torres Bozza、Peiwen Pan、Daniela Vullo、Seppo Parkkila、Claudiu T. Supuran、Clemente Capasso、Alcino Palermo Aguiar、Alane Beatriz Vermelho

  DOI：10.1021/jm400902y

  日期：2014.1.23

  Today, there are approximately 8 million cases of Chagas disease in the southern cone of South America alone, and about 100 million people are living with the risk of becoming infected. The present pharmacotherapy is sometimes ineffective and has serious side effects. Here, we report a series of 4,5 ''. -dihydroisoxazoles incorporating hydroxamate moieties, which act as effective inhibitors of the carbonic anhydrase (CA) from Trypanosoma cruzi (TcCA). One compound (5g)was evaluated in detail and shows promising features as an antitrypanosomal agent. Excellent values for the inhibition of growth for all three developmental forms of the parasite were observed at low concentrations of 5g (IC50 values from 7.0 to <1 mu M). The compound has a selectivity index (SI) of 6.7 and no cytotoxicity to macrophage cells. Preliminary in vivo data showed that 5g reduces bloodstream parasites and that all treated mice survived; it was also more effective than the standard drug benznidazole.
• Design and synthesis of spiro derivatives of parthenin as novel anti-cancer agents
  作者：Doma Mahendhar Reddy、Naveed A. Qazi、Sanghpal D. Sawant、Abid H. Bandey、Jada Srinivas、Mannepalli Shankar、Shashank K. Singh、Monika Verma、Gousia Chashoo、Arpita Saxena、Dilip Mondhe、Ajit K. Saxena、V.K. Sethi、Subhash C. Taneja、Gulam N. Qazi、H.M. Sampath Kumar

  DOI：10.1016/j.ejmech.2011.04.030

  日期：2011.8

  Several novel Spiro derivatives of parthenin (1) have been synthesized by the dipolar cycloaddition using various dipoles viz; benzonitrile oxides, nitrones and azides with exocyclic double bond of C ring (alpha-methylene-gamma-butyrolactone). Majority of the compounds exhibited improved anti-cancer activity compared to the parthenin, when screened for their in vitro cytotoxicity against three human cancer cell lines viz., SW-620, DU-145 and PC-3. In vivo screening of select analog revealed improved anti-cancer activity with low mammalian toxicity as compared to parthenin. The results of the cytotoxicity pattern of these derivatives reveals the SAR of these sesquiterpinoid lactones and possible role of alpha,beta-unsaturated ketone of parthenin in inhibiting NF-kB. A mechanistic correlation of anti-cancer activity along with in vivo and western blotting experiments has been described. (C) 2011 Elsevier Masson SAS. All rights reserved.
• FISERA L.; KOZINA N. D.; BADOVSKAYA L. A.; STIBRANYI L., CHEM. PAP., 40,(1986) N 5, 685-692
  作者：FISERA L.、 KOZINA N. D.、 BADOVSKAYA L. A.、 STIBRANYI L.

  DOI：——

  日期：——